Development of poly(ADP-ribose) polymerase inhibitor and immunotherapy combinations: progress, pitfalls, and promises

Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.trecan.2021.05.004

DC Field	Value
dc.title	Development of poly(ADP-ribose) polymerase inhibitor and immunotherapy combinations: progress, pitfalls, and promises
dc.contributor.author	Pham, Melissa M
dc.contributor.author	Ngoi, Natalie YL
dc.contributor.author	Peng, Guang
dc.contributor.author	Tan, David SP
dc.contributor.author	Yap, Timothy A
dc.date.accessioned	2021-07-14T03:17:07Z
dc.date.available	2021-07-14T03:17:07Z
dc.date.issued	2021-06
dc.identifier.citation	Pham, Melissa M, Ngoi, Natalie YL, Peng, Guang, Tan, David SP, Yap, Timothy A (2021-06). Development of poly(ADP-ribose) polymerase inhibitor and immunotherapy combinations: progress, pitfalls, and promises. Trends in Cancer. ScholarBank@NUS Repository. https://doi.org/10.1016/j.trecan.2021.05.004
dc.identifier.issn	24058033
dc.identifier.uri	https://scholarbank.nus.edu.sg/handle/10635/194100
dc.publisher	Elsevier BV
dc.source	Elements
dc.type	Article
dc.date.updated	2021-07-13T23:24:43Z
dc.contributor.department	MEDICINE
dc.description.doi	10.1016/j.trecan.2021.05.004
dc.description.sourcetitle	Trends in Cancer
dc.published.state	Published
Appears in Collections:	Staff Publications Elements

File	Description	Size	Format	Access Settings	Version
Trends cancer pham.pdf		689.17 kB	Adobe PDF	CLOSED	Published

Check